ARMP

Healthcare Biotechnology

Armata Pharmaceuticals, Inc.

$3.85

+0.19 +5.19% today

Price History

Not enough data

Key Stats

Market Cap

143.15M

Avg Volume

210,281

EPS

-$5.29

52W High

$16.34

52W Low

$3.09

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-1.89

P/B Ratio

-0.62

P/S Ratio

25.83

EV/EBITDA

-12.74

EV/Revenue

76.87

Margins

Gross Margin (217.4%)

Operating Margin (410.8%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

15.7%

Return on Assets

(25.8%)

Liquidity & Leverage

Current Ratio

0.11

Quick Ratio

0.11

Total Cash

23.95M

Total Debt

313.95M

About

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.